Publications by authors named "Xinan Fang"
J Gastrointest Oncol
December 2023
Article Synopsis
- Peritoneal metastases are common and have a poor prognosis in stage IV gastric cancer, with the need for effective treatments still being a challenge.
- A 39-year-old male patient treated with a combination of immunotherapy (camrelizumab), anti-angiogenic therapy (apatinib), and chemotherapy achieved significant tumor regression and became eligible for surgery after initially progressing on standard chemotherapy.
- This combination therapy showed promising anti-tumor effects and manageable safety, suggesting it could be a viable option for improving outcomes in patients with advanced gastric cancer and peritoneal metastases.
